Notably, a higher nine-IRPG risk score was positively correlated to the vascular invasion, extension of prothrombin time INR, Child-Pugh B stage, and AFP > 400, which indicated that the nine-IRGP signature was a potential biomarker for predicting HCC progression. This evidence concerns the gene F2 and hepatocellular carcinoma.